SPECTRUM PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Spectrum Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q1 2023.
  • Spectrum Pharmaceuticals Inc Operating Income (Loss) for the quarter ending March 31, 2023 was -$4.87M, a 65.4% increase year-over-year.
  • Spectrum Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending March 31, 2023 was -$63.5M, a 50.4% increase year-over-year.
  • Spectrum Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$72.7M, a 50.8% increase from 2021.
  • Spectrum Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$148M, a 13% increase from 2020.
  • Spectrum Pharmaceuticals Inc annual Operating Income (Loss) for 2020 was -$170M, a 20.6% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$63.5M -$4.87M +$9.19M +65.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$72.7M -$11.6M +$25.2M +68.4% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$97.9M -$21.6M +$11.5M +34.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$109M -$25.4M +$18.7M +42.4% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 -$128M -$14.1M +$19.6M +58.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$148M -$36.9M +$26M +41.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$174M -$33.1M +$6.48M +16.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$180M -$44.1M -$7.58M -20.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$173M -$33.7M -$2.9M -9.42% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$170M -$62.9M -$24.5M -64% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-31
Q3 2020 -$145M -$39.6M -$9.28M -30.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$136M -$36.5M -$2.28M -6.66% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$134M -$30.8M +$7.05M +18.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$141M -$38.4M +$8.1M +17.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$149M -$30.3M -$1.87M -6.58% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-31
Q2 2019 -$147M -$34.2M -$1.23M -3.72% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-31
Q1 2019 -$146M -$37.8M -$7.86M -26.2% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-31
Q4 2018 -$138M -$46.5M -$5.37M -13.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$132M -$28.4M -$13.4M -88.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$119M -$33M -$14.4M -77.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$105M -$30M -$8.07M -36.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$96.7M -$41.1M -$23.2M -129% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$73.5M -$15.1M +$1.13M +6.97% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$74.6M -$18.6M +$3.67M +16.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$78.3M -$21.9M -$15.4M -237% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$62.9M -$17.9M -$15M -505% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$47.9M -$16.2M -$107K -0.67% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$47.8M -$22.3M -$22.2M -65435% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$25.6M -$6.49M +$15.2M +70% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$40.7M -$2.96M -$1.33M -81.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$39.4M -$16.1M -$11.9M -289% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$27.5M -$34K* +$1.36M +97.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$28.8M -$21.7M +$2.75M +11.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$31.6M -$1.63M +$4.88M +74.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$36.4M -$4.13M +$9.16M +68.9% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$45.6M -$1.4M +$11.1M +88.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$56.7M -$24.4M -$18M -278% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$38.8M -$6.51M -$17.6M -159% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-13
Q3 2013 -$21.2M -$13.3M -$36.4M -157% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-13
Q2 2013 $15.2M -$12.5M -$35.6M -154% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-13
Q1 2013 $50.7M -$6.46M -$30.1M -127% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-13
Q4 2012 $80.8M $11M +$1.38M +14.3% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-12
Q3 2012 $79.4M $23.1M +$5.06M +28% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-12
Q2 2012 $74.3M $23M +$13.1M +132% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-12
Q1 2012 $61.2M $23.6M +$6.09M +34.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-12
Q4 2011 $55.1M $9.66M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 $18.1M +$24.9M Jul 1, 2011 Sep 30, 2011 10-K 2013-02-28
Q2 2011 $9.92M +$22.2M Apr 1, 2011 Jun 30, 2011 10-K 2013-02-28
Q1 2011 $17.5M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-28
Q3 2010 -$6.88M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-28
Q2 2010 -$12.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.